Richard Kim, DO
Rheumatology · Greenville, SCNPI 1699748459
Payments from drug & device makers
Across 1,042 payments — averaging $677.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$644K
- AstraZeneca$43K
- Amgen$4K
- AbbVie$3K
- Johnson & Johnson$2K
- UCB, Inc.$1K
- plus $9K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 46 | $644,021 |
| AstraZeneca(2 entities) | 49 | $43,452 |
| Amgen(2 entities) | 221 | $3,896 |
| AbbVie | 112 | $2,596 |
| Johnson & Johnson | 111 | $1,926 |
| UCB, Inc. | 75 | $1,284 |
| E.r. Squibb & Sons, L.L.C. | 53 | $1,153 |
| GSK | 41 | $1,029 |
| Novartis | 45 | $948 |
| Boehringer Ingelheim | 38 | $809 |
| Pfizer | 45 | $781 |
| Lilly USA, LLC | 45 | $773 |
| Mallinckrodt Hospital Products Inc. | 32 | $699 |
| ANI Pharmaceuticals, Inc. | 25 | $658 |
| Sanofi | 19 | $492 |
| Organon | 12 | $252 |
| Radius Health, Inc. | 9 | $187 |
| Aurinia Pharma U.S., Inc. | 11 | $173 |
| Sobi, Inc | 8 | $171 |
| Genentech USA, Inc. | 9 | $146 |
| Sandoz | 6 | $104 |
| Bioventus LLC | 6 | $89 |
| Fresenius Kabi USA, LLC | 4 | $86 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $82 |
| Bristol Myers Squibb | 3 | $64 |
| Actelion Pharmaceuticals US, Inc. | 2 | $47 |
| Scilex Pharmaceuticals Inc. | 2 | $37 |
| Boston Scientific | 1 | $34 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Merck | 2 | $25 |
| Tersera Therapeutics LLC | 1 | $22 |
| Invivyd Inc | 1 | $15 |
| Avanos Medical | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $15 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
How this compares
$706,122 in reported general payments places this provider in the 90th percentile of 123 rheumatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Greenville
- Alan BrownGreenville$947K
- Long Huynh-DucGreenville$475K
- Jeffrey LawsonGreenville$370K
- Corey EphrussiGreenville$54K
- Suhail KumarGreenville$34K
- David ZelmanGreenville$25K
- Gulzar MerchantGreenville$18K
- Ezinma EzealahGreenville$12K
- Stephen MullisGreenville$8K
- Josette JohnsonGreenville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.